vs
Side-by-side financial comparison of Smith Douglas Homes Corp. (SDHC) and Bio-Techne (TECH). Click either name above to swap in a different company.
Bio-Techne is the larger business by last-quarter revenue ($295.9M vs $260.4M, roughly 1.1× Smith Douglas Homes Corp.). Bio-Techne runs the higher net margin — 12.8% vs 1.4%, a 11.5% gap on every dollar of revenue. On growth, Bio-Techne posted the faster year-over-year revenue change (-6.4% vs -9.4%). Over the past eight quarters, Smith Douglas Homes Corp.'s revenue compounded faster (17.3% CAGR vs 4.2%).
Smith & Wesson Brands, Inc. (S&W) is an American firearm manufacturer headquartered in Maryville, Tennessee, United States.
Bio-Techne Corporation is an American life sciences company that develops, manufactures and sells life science reagents, instruments and services for the research, diagnostic, and bioprocessing markets.
SDHC vs TECH — Head-to-Head
Income Statement — Q4 FY2025 vs Q2 FY2026
| Metric | | |
|---|---|---|
| Revenue | $260.4M | $295.9M |
| Net Profit | $3.5M | $38.0M |
| Gross Margin | 19.9% | 64.6% |
| Operating Margin | 6.5% | 18.4% |
| Net Margin | 1.4% | 12.8% |
| Revenue YoY | -9.4% | -6.4% |
| Net Profit YoY | -14.3% | 68.3% |
| EPS (diluted) | $0.39 | $0.24 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | $260.4M | $295.9M | ||
| Q3 25 | $262.0M | — | ||
| Q2 25 | $223.9M | $317.0M | ||
| Q1 25 | $224.7M | $316.2M | ||
| Q4 24 | $287.5M | $297.0M | ||
| Q3 24 | $277.8M | $289.5M | ||
| Q2 24 | $220.9M | $306.1M | ||
| Q1 24 | $189.2M | $303.4M |
| Q4 25 | $3.5M | $38.0M | ||
| Q3 25 | $2.1M | — | ||
| Q2 25 | $2.4M | $-17.7M | ||
| Q1 25 | $2.7M | $22.6M | ||
| Q4 24 | $4.1M | $34.9M | ||
| Q3 24 | $5.3M | $33.6M | ||
| Q2 24 | $3.6M | $40.6M | ||
| Q1 24 | $3.0M | $49.1M |
| Q4 25 | 19.9% | 64.6% | ||
| Q3 25 | 21.0% | — | ||
| Q2 25 | 23.2% | 62.7% | ||
| Q1 25 | 23.8% | 67.9% | ||
| Q4 24 | 25.5% | 65.3% | ||
| Q3 24 | 26.5% | 63.2% | ||
| Q2 24 | 26.7% | 66.4% | ||
| Q1 24 | 26.1% | 67.4% |
| Q4 25 | 6.5% | 18.4% | ||
| Q3 25 | 6.6% | — | ||
| Q2 25 | 7.7% | -7.5% | ||
| Q1 25 | 8.7% | 12.2% | ||
| Q4 24 | 10.4% | 16.0% | ||
| Q3 24 | 14.2% | 13.8% | ||
| Q2 24 | 11.7% | 15.0% | ||
| Q1 24 | 11.3% | 22.1% |
| Q4 25 | 1.4% | 12.8% | ||
| Q3 25 | 0.8% | — | ||
| Q2 25 | 1.1% | -5.6% | ||
| Q1 25 | 1.2% | 7.1% | ||
| Q4 24 | 1.4% | 11.7% | ||
| Q3 24 | 1.9% | 11.6% | ||
| Q2 24 | 1.7% | 13.3% | ||
| Q1 24 | 1.6% | 16.2% |
| Q4 25 | $0.39 | $0.24 | ||
| Q3 25 | $0.24 | — | ||
| Q2 25 | $0.26 | $-0.11 | ||
| Q1 25 | $0.30 | $0.14 | ||
| Q4 24 | $0.50 | $0.22 | ||
| Q3 24 | $0.58 | $0.21 | ||
| Q2 24 | $0.40 | $0.26 | ||
| Q1 24 | $0.33 | $0.31 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $12.7M | $172.9M |
| Total DebtLower is stronger | — | $260.0M |
| Stockholders' EquityBook value | $86.7M | $2.0B |
| Total Assets | $557.6M | $2.5B |
| Debt / EquityLower = less leverage | — | 0.13× |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $12.7M | $172.9M | ||
| Q3 25 | $14.8M | — | ||
| Q2 25 | $16.8M | $162.2M | ||
| Q1 25 | $12.7M | $140.7M | ||
| Q4 24 | $22.4M | $177.5M | ||
| Q3 24 | $23.7M | $187.5M | ||
| Q2 24 | $17.3M | $152.9M | ||
| Q1 24 | $32.8M | $145.3M |
| Q4 25 | — | $260.0M | ||
| Q3 25 | — | — | ||
| Q2 25 | — | $346.0M | ||
| Q1 25 | — | $330.0M | ||
| Q4 24 | — | $300.0M | ||
| Q3 24 | — | $300.0M | ||
| Q2 24 | — | $319.0M | ||
| Q1 24 | — | $389.0M |
| Q4 25 | $86.7M | $2.0B | ||
| Q3 25 | $82.2M | — | ||
| Q2 25 | $80.0M | $1.9B | ||
| Q1 25 | $76.9M | $2.0B | ||
| Q4 24 | $73.6M | $2.1B | ||
| Q3 24 | $68.4M | $2.1B | ||
| Q2 24 | $62.1M | $2.1B | ||
| Q1 24 | $59.7M | $2.0B |
| Q4 25 | $557.6M | $2.5B | ||
| Q3 25 | $571.6M | — | ||
| Q2 25 | $570.2M | $2.6B | ||
| Q1 25 | $513.9M | $2.6B | ||
| Q4 24 | $475.9M | $2.7B | ||
| Q3 24 | $460.1M | $2.7B | ||
| Q2 24 | $429.3M | $2.7B | ||
| Q1 24 | $401.3M | $2.7B |
| Q4 25 | — | 0.13× | ||
| Q3 25 | — | — | ||
| Q2 25 | — | 0.18× | ||
| Q1 25 | — | 0.16× | ||
| Q4 24 | — | 0.14× | ||
| Q3 24 | — | 0.14× | ||
| Q2 24 | — | 0.15× | ||
| Q1 24 | — | 0.19× |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $9.8M | — |
| Free Cash FlowOCF − Capex | $8.7M | — |
| FCF MarginFCF / Revenue | 3.4% | — |
| Capex IntensityCapex / Revenue | 0.4% | — |
| Cash ConversionOCF / Net Profit | 2.77× | — |
| TTM Free Cash FlowTrailing 4 quarters | $-36.9M | — |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $9.8M | — | ||
| Q3 25 | $22.8M | — | ||
| Q2 25 | $-28.9M | $98.2M | ||
| Q1 25 | $-34.9M | $41.1M | ||
| Q4 24 | $5.5M | $84.3M | ||
| Q3 24 | $22.9M | $63.9M | ||
| Q2 24 | $39.0K | $75.5M | ||
| Q1 24 | $-9.3M | $81.0M |
| Q4 25 | $8.7M | — | ||
| Q3 25 | $21.4M | — | ||
| Q2 25 | $-31.1M | $93.3M | ||
| Q1 25 | $-35.9M | $31.0M | ||
| Q4 24 | $4.8M | $77.5M | ||
| Q3 24 | $22.3M | $54.7M | ||
| Q2 24 | $-2.1M | $57.5M | ||
| Q1 24 | $-9.7M | $64.5M |
| Q4 25 | 3.4% | — | ||
| Q3 25 | 8.2% | — | ||
| Q2 25 | -13.9% | 29.4% | ||
| Q1 25 | -16.0% | 9.8% | ||
| Q4 24 | 1.7% | 26.1% | ||
| Q3 24 | 8.0% | 18.9% | ||
| Q2 24 | -1.0% | 18.8% | ||
| Q1 24 | -5.1% | 21.3% |
| Q4 25 | 0.4% | — | ||
| Q3 25 | 0.5% | — | ||
| Q2 25 | 0.9% | 1.5% | ||
| Q1 25 | 0.5% | 3.2% | ||
| Q4 24 | 0.2% | 2.3% | ||
| Q3 24 | 0.2% | 3.2% | ||
| Q2 24 | 1.0% | 5.9% | ||
| Q1 24 | 0.2% | 5.4% |
| Q4 25 | 2.77× | — | ||
| Q3 25 | 10.70× | — | ||
| Q2 25 | -12.24× | — | ||
| Q1 25 | -13.01× | 1.82× | ||
| Q4 24 | 1.33× | 2.42× | ||
| Q3 24 | 4.28× | 1.90× | ||
| Q2 24 | 0.01× | 1.86× | ||
| Q1 24 | -3.12× | 1.65× |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
SDHC
| Southeast | $164.7M | 63% |
| Central | $95.8M | 37% |
TECH
| Diagnostics And Spatial Biology | $81.2M | 27% |
| EMEA Excluding UK | $75.4M | 25% |
| Other | $42.4M | 14% |
| Instruments | $29.6M | 10% |
| APAC Excluding Greater China | $22.7M | 8% |
| Services | $22.3M | 8% |
| GB | $13.7M | 5% |
| Royalty | $8.5M | 3% |
